Search Results - Martin Bak
- Showing 1 - 18 results of 18
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Demokrati som transgression by Martin Bak Jørgensen, Óscar García Agustín
Published in Akademisk Kvarter (2011-12-01)Get full text
Article -
9
Book Reviews by Henning Eichberg, Martin Bak Jørgensen, Miguel Benito, Veronica Ferreri, Erdem Dikici
Published in Nordic Journal of Migration Research (2016-04-01)Get full text
Article -
10
Book Reviews by Jesse Sargent, Stephen Richard Trotter, Casper Jacobsen, Lise Widding Isaksen, Martin Bak Jørgensen
Published in Nordic Journal of Migration Research (2017-09-01)Get full text
Article -
11
SRC drives growth of antiestrogen resistant breast cancer cell lines and is a marker for reduced benefit of tamoxifen treatment. by Sarah L Larsen, Anne-Vibeke Laenkholm, Anne Katrine Duun-Henriksen, Martin Bak, Anne E Lykkesfeldt, Tove Kirkegaard
Published in PLoS ONE (2015-01-01)Get full text
Article -
12
Intratumor Genetic Heterogeneity of Breast Carcinomas as Determined by Fine Needle Aspiration and TaqMan Low Density Array by Maria B. Lyng, Anne-Vibeke Lænkholm, Niels Pallisgaard, Werner Vach, Ann Knoop, Martin Bak, Henrik J. Ditzel
Published in Cellular Oncology (2007-01-01)Get full text
Article -
13
Outcome of breast cancer screening in Denmark by Elsebeth Lynge, Martin Bak, My von Euler-Chelpin, Niels Kroman, Anders Lernevall, Nikolaj Borg Mogensen, Walter Schwartz, Adam Jan Wronecki, Ilse Vejborg
Published in BMC Cancer (2017-12-01)Get full text
Article -
14
Ensemble‐based classification using microRNA expression identifies a breast cancer patient subgroup with an ultralow long‐term risk of metastases by Ines Block, Mark Burton, Kristina P. Sørensen, Martin J. Larsen, Thi T. N. Do, Martin Bak, Søren Cold, Mads Thomassen, Qihua Tan, Torben A. Kruse
Published in Cancer Medicine (2024-05-01)Get full text
Article -
15
Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer by Abeer J. Al-Qasem, Carla L. Alves, Sidse Ehmsen, Martina Tuttolomondo, Mikkel G. Terp, Lene E. Johansen, Henriette Vever, Luna V. A. Hoeg, Daniel Elias, Martin Bak, Henrik J. Ditzel
Published in npj Precision Oncology (2022-09-01)Get full text
Article -
16
RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer by Charlotte K. Kindt, Sidse Ehmsen, Sidse Ehmsen, Sidse Ehmsen, Sofie Traynor, Benedetta Policastro, Nikoline Nissen, Mie K. Jakobsen, Monique F. Hundebøl, Lene E. Johansen, Martin Bak, Elsa Arbajian, Johan Staaf, Henrik J. Ditzel, Henrik J. Ditzel, Henrik J. Ditzel, Carla L. Alves
Published in Frontiers in Oncology (2025-01-01)Get full text
Article -
17
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit by Sanne Løkkegaard, Daniel Elias, Carla L. Alves, Martin V. Bennetzen, Anne-Vibeke Lænkholm, Martin Bak, Morten F. Gjerstorff, Lene E. Johansen, Henriette Vever, Christina Bjerre, Tove Kirkegaard, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Linda S. Lindström, Laura J. Esserman, Anne E. Lykkesfeldt, Jens S. Andersen, Rikke Leth-Larsen, Henrik J. Ditzel
Published in npj Breast Cancer (2021-01-01)Get full text
Article -
18
An in situ depot for the sustained release of a TLR7/8 agonist in combination with a TGFβ inhibitor promotes anti-tumor immune responses by Sophie B. Jensen, Ditte E. Jæhger, Elizabeth Serrano-Chávez, Hólmfríður R. Halldórsdóttir, Trine B. Engel, Jennifer S. Jørgensen, Unnur J. Björgvinsdóttir, Serhii Kostrikov, Marouschka J. Scheeper, Lars Ringgaard, Linda M. Bruun, Camilla Stavnsbjerg, Esben Christensen, Martin Bak, Julianna Thuroczy, Lajos Balogh, Andreas T. I. Jensen, Fredrik Melander, Andreas Kjaer, Jonas R. Henriksen, Anders E. Hansen, Thomas L. Andresen
Published in Nature Communications (2024-09-01)Get full text
Article
